(Stroke. 2000;31:2218.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurosurgery (S.K., T.S.P., E.G., J.M.G.), Cell Biology and Physiology (J.M.G.), and Anatomy and Neurobiology (T.S.P.), and St Louis Childrens Hospital (T.S.P., J.M.G.), Washington University School of Medicine, St Louis, Mo.
Background and PurposeHydroxyethyl starch (HES) has beneficial effects on ischemic brain injury; however, its mechanism of action remains unclear. The present study was undertaken to test the hypothesis that HES can attenuate increases in leukocyte adherence and vascular permeability in the cerebral vasculature after global cerebral ischemia induced by asphyxia.
MethodsPial venular leukocyte adherence and permeability to sodium fluorescein were quantified in anesthetized newborn piglets by in situ fluorescence videomicroscopy through closed cranial windows during basal conditions and during 2 hours of reperfusion after global ischemia induced by 9 minutes of asphyxia. Experimental animals received HES after the asphyxial insult (10% HES 257/0.47, 600 mg/kg IV bolus 5 minutes after asphyxia, followed by 600 mg/kg per hour IV drip during reperfusion; n=9).
ResultsA progressive and significant (P<0.05) increase in adherent leukocytes was observed during the initial 2 hours of reperfusion after asphyxia compared with nonasphyxial controls. In this model, vascular injury, as determined by significant (P<0.05) increases in fluorescein permeability at 2 hours of reperfusion, is largely dependent on adherent leukocytes. HES significantly reduced (P<0.05) leukocyte adherence at 1 hour and 2 hours of reperfusion and reduced fluorescein permeability at 2 hours. HES did not change hematocrit or alter pial arteriolar diameter.
ConclusionsThese findings indicate that a vascular anti-inflammatory action may underlie the beneficial effects of HES in global cerebral ischemia secondary to asphyxia. Since this compound is well tolerated by patients, future preclinical and clinical studies may reveal improvements in functional outcome with the early introduction of this or similar agents after perinatal asphyxia or global ischemia.
University of California, San Diego, Department of Neurosciences, La Jolla, California
This article has been cited by other articles:
![]() |
R. Lv, Z.-Q. Zhou, H.-W. Wu, Y. Jin, W. Zhou, and J.-G. Xu Hydroxyethyl starch exhibits antiinflammatory effects in the intestines of endotoxemic rats. Anesth. Analg., July 1, 2006; 103(1): 149 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lv, W. Zhou, C. Chu, and J. Xu Mechanism of the Effect of Hydroxyethyl Starch on Reducing Pulmonary Capillary Permeability in a Rat Model of Sepsis Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Iriz, F. Kolbakir, H. Akar, B. Adam, and H. T. Keceligil Comparison of Hydroxyethyl Starch and Ringer Lactate as a Prime Solution Regarding S-100{beta} Protein Levels and Informative Cognitive Tests in Cerebral Injury Ann. Thorac. Surg., February 1, 2005; 79(2): 666 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, X. Lin, W. Zhou, and J. Xu Hydroxyethyl Starch Inhibits NF-{kappa}B Activation and Prevents the Expression of Inflammatory Mediators in Endotoxic Rats Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 451 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Dieterich, J. Reutershan, T. W. Felbinger, and H. K. Eltzschig Penetration of Intravenous Hydroxyethyl Starch into the Cerebrospinal Fluid in Patients with Impaired Blood-Brain Barrier Function Anesth. Analg., April 1, 2003; 96(4): 1150 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Belayev, E. Pinard, H. Nallet, J. Seylaz, Y. Liu, P. Riyamongkol, W. Zhao, R. Busto, and M. D. Ginsberg Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses Stroke, April 1, 2002; 33(4): 1077 - 1084. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |